| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.92▼ | 2.99▼ | 2.99▼ | 2.06▲ | 1.05▲ |
| MA10 | 2.92▼ | 2.98▼ | 2.90▼ | 1.29▲ | 0.75▲ |
| MA20 | 2.96▼ | 2.91▼ | 2.65▲ | 0.84▲ | 0.82▲ |
| MA50 | 2.99▼ | 2.29▲ | 1.65▲ | 0.61▲ | 2.53▲ |
| MA100 | 2.95▼ | 1.55▲ | 1.02▲ | 0.78▲ | 9.59▼ |
| MA200 | 2.67▲ | 0.98▲ | 0.69▲ | 2.12▲ | 39.74▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.044▼ | -0.021▼ | 0.273▲ | 0.367▲ |
| RSI | 42.269▼ | 54.792▲ | 61.374▲ | 86.652▲ | 63.265▲ |
| STOCH | 40.726 | 51.586 | 58.298 | 68.383 | 36.331 |
| WILL %R | -79.412▼ | -63.743 | -29.781 | -29.810 | -29.412 |
| CCI | -91.988 | -44.483 | 41.006 | 173.533▲ | 372.879▲ |
|
Friday, May 22, 2026 04:39 PM
HCW Biologics ( (HCWB) ) has provided an announcement.
|
|
Friday, May 22, 2026 01:11 PM
Rallo, Chief Executive Officer of E.F. Hutton & Co., commented, “We are pleased to have partnered with HCW Biologics on this important financing transaction. HCW Biologics continues to advance a ...
|
|
Thursday, May 21, 2026 07:17 AM
HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to treat autoimmune, cancer and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/05/26 | 3.22 | 3.48 | 2.70 | 2.89 | 19,433,551 |
| 21/05/26 | 2.17 | 2.92 | 1.6001 | 2.58 | 20,456,088 |
| 20/05/26 | 1.04 | 3.99 | 1.04 | 2.43 | 190,617,766 |
| 19/05/26 | 1.23 | 1.2967 | 1.00 | 1.06 | 8,693,676 |
| 18/05/26 | 1.15 | 1.60 | 0.9481 | 1.34 | 36,098,506 |
| 15/05/26 | 1.11 | 1.42 | 0.991 | 1.22 | 389,360,388 |
| 14/05/26 | 0.3535 | 0.3609 | 0.3368 | 0.337 | 326,858 |
| 13/05/26 | 0.3446 | 0.36 | 0.3351 | 0.3494 | 236,337 |
| 12/05/26 | 0.301 | 0.3616 | 0.301 | 0.3396 | 274,866 |
| 11/05/26 | 0.3261 | 0.3261 | 0.30 | 0.3084 | 137,663 |
|
|
||||
|
|
||||
|
|